Retatrutide is a new weight loss injection showing promise among the popular fat loss medications Wegovy/Ozempic (semaglutide) and Zepbound/Mounjaro (tirzepatide)
Both peptides deliver bioavailable copper to scalp tissue, which is a required cofactor for lysyl oxidase (collagen cross-linking), superoxide dismutase (antioxidant defense), and other enzymes involved in tissue repair and maintenance
Patients use a pre-filled pen to administer the dose subcutaneously, usually in the thigh, abdomen, or upper arm
Comparative Incretin Research: Retatrutide has been studied in direct comparison with dual agonists like Tirzepatide and single agonists like Semaglutide in pre-clinical models, with research examining how the addition of GCGR agonism modifies metabolic outcomes providing direct pharmacological insight into the incremental value of each receptor target within the tri-agonist framework
The sticky residue requires a little time to dissipate
GHK-Cu, CJC-1295 + Ipamorelin, and BPC-157 Advanced anti-aging protocols sometimes combine: Growth hormone support peptides Recovery peptides Regenerative skin peptides Because these therapies influence multiple biological pathways, physician supervision is essential